These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 39345911)
1. The Application of Nanotechnology for the Diagnosis and Treatment of Endocrine Disorders: A Review of Current Trends, Toxicology and Future Perspective. Yan Y; Cai H; Yang M Int J Nanomedicine; 2024; 19():9921-9942. PubMed ID: 39345911 [TBL] [Abstract][Full Text] [Related]
2. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices. Zhang Y; Tang N; Zhou H; Zhu Y Biomed Pharmacother; 2024 Jul; 176():116840. PubMed ID: 38820975 [TBL] [Abstract][Full Text] [Related]
3. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface. Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Lam PL; Wong WY; Bian Z; Chui CH; Gambari R Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; GrazĂș V; Borm P; Estrada G; Ntziachristos V; Razansky D Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661 [TBL] [Abstract][Full Text] [Related]
7. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609 [TBL] [Abstract][Full Text] [Related]
8. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine. Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081 [TBL] [Abstract][Full Text] [Related]
9. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic. Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391 [TBL] [Abstract][Full Text] [Related]
10. A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Jahangirian H; Lemraski EG; Webster TJ; Rafiee-Moghaddam R; Abdollahi Y Int J Nanomedicine; 2017; 12():2957-2978. PubMed ID: 28442906 [TBL] [Abstract][Full Text] [Related]
11. A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches. Kashani GK; Naghib SM; Soleymani S; Mozafari MR Int J Biol Macromol; 2024 May; 268(Pt 1):131694. PubMed ID: 38642693 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032 [TBL] [Abstract][Full Text] [Related]
13. Veterinary nanomedicine: Pros and cons. Jafary F; Motamedi S; Karimi I Vet Med Sci; 2023 Jan; 9(1):494-506. PubMed ID: 36580403 [TBL] [Abstract][Full Text] [Related]
14. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications. Yanar F; Carugo D; Zhang X Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666 [TBL] [Abstract][Full Text] [Related]
15. Nanotechnology, A Tool for Diagnostics and Treatment of Cancer. Nasir A; Khan A; Li J; Naeem M; Khalil AAK; Khan K; Qasim M Curr Top Med Chem; 2021; 21(15):1360-1376. PubMed ID: 34218784 [TBL] [Abstract][Full Text] [Related]
16. Nanomedicines for kidney diseases. Williams RM; Jaimes EA; Heller DA Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222 [TBL] [Abstract][Full Text] [Related]
17. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Dreaden EC; El-Sayed MA Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051 [TBL] [Abstract][Full Text] [Related]
19. Evaluating Nanomedicines: Obstacles and Advancements. Swierczewska M; Crist RM; McNeil SE Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088 [TBL] [Abstract][Full Text] [Related]
20. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases. Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]